Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE

Standard Dose
0.25%;0.005MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 071167 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE Form and strength INJECTABLE;INJECTION - 0.25%;0.005MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2021-07-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 071167 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE Form and strength INJECTABLE;INJECTION - 0.25%;0.005MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2021-07-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.